Previous 10 | Next 10 |
2024-07-17 14:09:20 ET More on AbbVie, Bristol-Myers, etc. Is Bristol-Myers Squibb's Rich Dividend Yield Worth The Patent Cliff Correction Risk? Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript Don't Let The Market Fool You: Bristol-Myers Is Not A Value T...
2024-07-17 13:28:09 ET Summary Rotation trade sees shift to cyclical and defensive sectors. Housing starts rose 3.0% M/M in June. JNJ posted better-than-expected results. Listen below or on the go on Apple Podcasts and Spotify Money continues to l...
2024-07-17 13:21:54 ET Shares of Swiss pharmaceuticals company Roche Holding (OTC: RHHBY) soared 7% through 11:55 a.m. ET Wednesday on positive data from phase 1 clinical trials of its new weight loss drug CT-996. But good news for Roche is bad news for the companies that no...
2024-07-17 10:47:28 ET Summary Monthly article series reports aggregate industry metrics in healthcare. Healthcare providers and life science tools are moderately overvalued, while pharmaceuticals and biotechnology have the worst value and quality scores. Fidelity MSCI Health ...
2024-07-17 08:15:00 ET One thing that can make investing seem daunting and intimidating is how quickly things change in the markets. Knowing which stocks to own and which ones are hot buys right now can turn investing into a part-time job. But if you stick with large, established businesses...
2024-07-17 07:36:37 ET More on Eli Lilly, Novo Nordisk, etc. What Eli Lilly Is Getting With The Acquisition Of Morphic Holding Wall Street Lunch: Merger Monday In All Its Glory Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal Novo Nordi...
2024-07-16 13:01:00 ET Short percentage in S&P 500’s healthcare companies rose slightly at the end of June from May as biotechnology industry continued to emerge as the most shorted sector, while most other sectors saw meager change in interest from last month.... Read the ...
2024-07-16 08:10:00 ET Summary Stock market investing is not a zero-sum game, offering long-term potential for growth and income when it comes to highly undervalued stocks. Bristol Myers Squibb stock is undervalued, with strong revenue growth, profitability, and a promising drug p...
A look at the top 10 most actives in the United States American Rebel Holdings Inc. (AREB) rose 60.3% to $0.83355 on volume of 56,112,820 shares DatChat Inc. (DATS) rose 71.2% to $1.78 on volume of 33,845,116 shares Autonomix Medical Inc. (AMIX) rose 97.4% to $1.22 on volume of 33,054,234...
2024-07-15 07:45:00 ET When it comes to investing in growth stocks, a long-term mindset can be a lucrative advantage. Peering further into the future can enable you to position your portfolio for fortune-building gains. Here are two businesses with excellent long-term expansion prospects th...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...